{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:33:18Z","timestamp":1793068398910,"version":"4.5.0"},"reference-count":135,"publisher":"Informa UK Limited","issue":"11","funder":[{"name":"funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2021,11,2]]},"DOI":"10.1080\/14712598.2021.1907341","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T15:00:56Z","timestamp":1616770856000},"page":"1461-1471","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":19,"title":["The emerging role of dupilumab in dermatological indications"],"prefix":"10.1080","volume":"21","author":[{"given":"Maddalena","family":"Napolitano","sequence":"first","affiliation":[{"name":"Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Di Guida","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariateresa","family":"Nocerino","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Fabbrocini","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cataldo","family":"Patruno","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,3,30]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8111743"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.12.022"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.01.011"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2018.1449642"},{"key":"cit0005","volume-title":"DUPIXENTVR prescribing information","author":"Regeneron pharmaceuticals","year":"2018"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314768"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610020"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31191-1"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16156"},{"issue":"11","key":"cit0010","first-page":"e701","volume":"34","author":"Napolitano M","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19577"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804093"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31881-1"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16156"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610020"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1111\/all.13397"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.10.035"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.126782"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1097\/01.all.0000182540.45348.bc"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1111\/all.12616"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.11.018"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14081"},{"key":"cit0023","author":"F\u00f6hr J","year":"2020","journal-title":"Hautarzt"},{"issue":"20","key":"cit0024","first-page":"30441","volume":"1081","author":"Goodman B","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"cit0025","unstructured":"ClinicalTrials.gov. Dupilumab for the treatment of chronic spontaneous urticaria in patients who remain symptomatic despite the use of H1 antihistamine and who are na\u00efve to, intolerant of, or incomplete responders to omalizumab (CUPID). U.S. National Library of Medicine. Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04180488. [Last accessed 29 December 2020]"},{"key":"cit0026","unstructured":"ClinicalTrials.gov. Dupilumab in chronic spontaneous urticaria (DUPICSU) U.S. National Library of Medicine. [cited 2020 Dec 29]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03749135."},{"key":"cit0027","unstructured":"ClinicalTrials.gov. Cholinergic urticaria\u2014Efficacy of dupilumab (CHED). U.S. National Library of Medicine. [cited 2020 Dec 29]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03749148."},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2018.02.003"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14570"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12365"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.08.006"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10498.x"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0138"},{"key":"cit0034","first-page":"1","author":"Williams KA","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1111\/apha.12442"},{"issue":"9","key":"cit0036","first-page":"940","volume":"18","author":"Tanis R","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.3906"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.3912"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15957"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13201"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13222"},{"issue":"6","key":"cit0042","first-page":"e8737","volume":"12","author":"Wieser JK","year":"2020","journal-title":"Cureus"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3243"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15584"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.03.016"},{"key":"cit0046","volume":"230","author":"Romano C","year":"2020","journal-title":"J Investig Allergol Clin Immunol"},{"key":"cit0047","first-page":"1","author":"Ferrucci S","year":"2019","journal-title":"J Dermatolog Treat"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000517"},{"key":"cit0049","unstructured":"ClinicalTrials.gov. Study of dupilumab for the treatment of patients with prurigo nodularis, inadequately controlled on topical prescription therapies or when those therapies are not advisable (PRIME). U.S. National Library of Medicine. [cited 2020 Dec 29]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04183335."},{"key":"cit0050","unstructured":"ClinicalTrials.gov. Study of dupilumab for the treatment of patients with prurigo nodularis, inadequately controlled on topical prescription therapies or when those therapies are not advisable (PRIME2). U.S. National Library of Medicine. [cited 2020 Dec 29]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT04202679."},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0305"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3164"},{"issue":"20","key":"cit0053","first-page":"32063","volume":"0022","author":"Whang KA","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"2","key":"cit0054","doi-asserted-by":"crossref","DOI":"10.5070\/D3242038109","volume":"24","author":"Brummer GC","year":"2018","journal-title":"Dermatol Online J"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.3390\/medicines6030072"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2018.08.010"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.01.024"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18852"},{"key":"cit0059","unstructured":"Study on dupilumab for the treatment of moderate to severe chronic hepatic pruritus. [cited 2020 Dec 29]. Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04256759."},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20199007"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13190"},{"key":"cit0062","first-page":"34","volume":"46","author":"Maglie R","year":"2019","journal-title":"CurrOpinPharmacol"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2015.09.017"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.2526"},{"issue":"11","key":"cit0065","doi-asserted-by":"crossref","DOI":"10.5070\/D32511046147","volume":"25","author":"Seidman JS","year":"2019","journal-title":"Dermatol Online J"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.01.089"},{"key":"cit0067","unstructured":"ClinicalTrials.gov. A study to evaluate the efficacy and safety ofdupilumabin adult patients withbullous pemphigoid (LIBERTY-BP). U.S. National Library of Medicine. [cited 2020 Dec 29]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04206553."},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04629.x"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14129"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.11.007"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13208"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3183"},{"issue":"2","key":"cit0073","first-page":"534","volume":"179","author":"Darrigade AS","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"cit0074","first-page":"e72","volume":"48","author":"Muto J","year":"2020","journal-title":"J Dermatol"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.2976"},{"issue":"12","key":"cit0076","first-page":"1278","volume":"17","author":"Ludriksone L","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"key":"cit0077","author":"Szekely S","year":"2020","journal-title":"J Investig Allergol Clin Immunol"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.2915"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13023"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18976"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2019.3626"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14880"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0301"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000458"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2017.11.020"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.10.010"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.03.019"},{"key":"cit0088","author":"Carnicle JM","year":"2019","journal-title":"Dermatitis"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16493"},{"key":"cit0090","unstructured":"ClinicalTrials.gov. Treatment of alopecia areata (AA) with dupilumab in patients with and without atopic dermatitis (AD) 2020. U.S. National Library of Medicine. [cited 2020 Dec 29]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03359356."},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.03.009"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0340-7"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000446"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000409"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12701"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000414"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.01.023"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13545"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13266"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000357"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000346"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.07.043"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.12.048"},{"key":"cit0104","unstructured":"ClinicalTrials.gov. The effects of dupilumab on allergic contact dermatitis. U.S. National Library of Medicine. [cited 2020 Dec 29]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03935971."},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16061"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1007\/s00420-002-0418-1"},{"key":"cit0107","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2008.01362.x"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2010.04001.x"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14982"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.073"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.02.010"},{"key":"cit0112","author":"Loman L","year":"2020","journal-title":"Contact Dermatitis"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.2027"},{"key":"cit0114","doi-asserted-by":"publisher","DOI":"10.1159\/000496481"},{"key":"cit0115","unstructured":"ClinicalTrials.gov. Dupilumab in severe chronic hand eczema (DUPSHE). U.S. National Library of Medicine. [cited 2020 Dec 29]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04512339."},{"key":"cit0116","unstructured":"ClinicalTrials.gov. Efficacy and safety of dupilumab chronic hands eczema refractory to highly potent topical corticosteroids (DUPECZEMAIN). U.S. National Library of Medicine. [cited 2020 Dec 29]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03861455."},{"key":"cit0117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.12.053"},{"issue":"3","key":"cit0118","first-page":"355","volume":"17","author":"Weston GK","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"cit0119","first-page":"211","volume":"18","author":"Nanda S","year":"2019","journal-title":"J Drugs Dermatol"},{"issue":"11","key":"cit0120","first-page":"1165","volume":"17","author":"Weins AB","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"key":"cit0121","author":"Andreasen TH","year":"2020","journal-title":"ClinExpDermatol"},{"key":"cit0122","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.4608"},{"key":"cit0123","author":"S\u00fc\u00dfmuth K","year":"2020","journal-title":"J EurAcad Dermatol Venereol"},{"key":"cit0124","author":"Aktas M","year":"2020","journal-title":"PediatrDermatol"},{"key":"cit0125","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20163941"},{"key":"cit0126","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X19845235"},{"key":"cit0127","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.05.006"},{"key":"cit0128","author":"Eickstaedt JB","year":"2020","journal-title":"PediatrDermatol"},{"key":"cit0129","doi-asserted-by":"publisher","DOI":"10.1159\/000358588"},{"key":"cit0130","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.0946"},{"key":"cit0131","author":"Komatsu-Fujii T","year":"2020","journal-title":"J EurAcad Dermatol Venereol"},{"issue":"3","key":"cit0132","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5070\/D33ZS95220","volume":"18","author":"Sempau L","year":"2012","journal-title":"Dermatol Online J"},{"issue":"4","key":"cit0133","first-page":"e255","volume":"35","author":"Gordon SC","year":"2018","journal-title":"PediatrDermatol"},{"issue":"9","key":"cit0134","first-page":"1031","volume":"18","author":"Maione V","year":"2020","journal-title":"J Dtsch Dermatol Ges"},{"key":"cit0135","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18855"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2021.1907341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T12:57:46Z","timestamp":1636635466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2021.1907341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":135,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,2]]}},"alternative-id":["10.1080\/14712598.2021.1907341"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2021.1907341","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-01-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}